Published in:
Open Access
01-12-2015 | Meeting abstract
Association between type 1 diabetes mellitus and epilepsy: more than coincidence?
Authors:
Tiago Silva Aguiar, Joana Rodrigues Dantas Vezzani, Débora Batista de Araújo, Soniza Vieira Alves-Leon, Lenita Zajdenverg, Melanie Rodacki, Marco Antônio Salles Dantas de Lima
Published in:
Diabetology & Metabolic Syndrome
|
Special Issue 1/2015
Login to get access
Excerpt
Type 1 diabetes mellitus (T1D) patients have an increased risk of seizures at extremes of glycemic control. There is growing evidence about the role of autoimmunity in the epileptogenesis and glutamic acid decarboxylase antibodies (GAD-ab), a well known antibody related to neurologic diseases, can be a link that justifies epilepsy in T1D population. GAD catalyzes the conversion of glutamic acid, the main excitatory central nervous system (CNS) amino acid, into gamma-aminobutyric acid (GABA), the main inhibitory CNS neurotransmitter. GABA-secreting neurons and pancreatic beta cells are the major cells expressing GAD. Seizures may be result of imbalance between excitation and inhibition determined by inhibition of GAD activity caused by autoantibodies. The potential pathogenic role of GAD-ab in neurological disorders is not fully understood, but inhibition of GABA synthesis or interfering with the exocytosis are plausible hypotheses. The spectrum of neurological disorders associated with GAD-ab includes cerebellar ataxia, myoclonus palatal, limbic encephalitis, encephalomyelitis, stiff person syndrome and others. …